交易 Faron Pharmaceuticals Oy - FARN 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.021
• 长仓隔夜仓息调整: -0.02127%
• 短仓隔夜仓息调整: -0.00065%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: GBP
• 最低成交量: 10
• 保证金: 20.00%
• 证券交易所: Great Britain
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: N/A
• 开仓: 0.4295
• 1 年变化: -81.7%
• 日区间: 0.4195 - 0.4295

交易 Faron Pharmaceuticals Oy - FARN 差价合约

Faron Pharmaceuticals Oy (LSE: FARN) is a clinical-stage biopharmaceutical company based in Finland, focused on immunotherapies for cancer and acute inflammatory conditions. Its lead candidate, bexmarilimab, is being developed to enhance immune response in solid tumours and sepsis. Faron leverages scientific innovation and clinical partnerships to advance novel treatments for serious diseases.